Instruments + reagents + clinical diagnostics. Digital PCR/qPCR franchise creates recurring consumable pull. Consumables-heavy revenue mix.
Research snapshot · Not reviewed
BIOBio-Rad Laboratories
Instruments, reagents, consumables
Open BIO in Robinhood ↗Conviction●○○○○1 of 5
Research target—Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap$7.94BSnapshot value
PCR/clinical diagnostics volume growth; biopharma R&D spending; consumables pull-through from installed base.
Competitive pressure in PCR from Thermo/QIAGEN; academic budget sensitivity; slower growth profile vs peers.
needs X/Reddit sentiment sweep
Snapshot · Not reviewed🟢 Lean-Bull · ins-$0.3M · 13F 16+/8- · short↑0.38
Snapshot · Not reviewed